Overview

Rat Model Market is poised to value over USD 830.1 million by 2027 end at a CAGR of over 8.5% during the forecast period 2020 to 2027

FutureWise Market Research has instantiated a report that provides an intricate analysis of Rat Model Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Rat Model Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Rat Model Market:
• Charles River Laboratories International, Inc.
• Taconic Biosciences, Inc.
• Envigo
• Laboratory Corporation of America Holdings
• Janvier Labs
• Genoway S.A.
• Biomere
• Transposagen Biopharmaceuticals, Inc.
• Horizon Discovery Group PLC
• Transviragen, Inc.
• SAGE Labs
• Covance, Inc.
• Biomedical Research Models
 (Note: The list of the major players will be updated with the latest market scenario and trends)

Rat Model Market Segmentation:
By Model Type
• Outbred Rats
• Inbred Rats
• Knockout/Genetically Engineered Rats
• Hybrid/Congenic Rats
• Conditioned/Surgically Modified Rats
• Immunodeficient Rats

By Service
• Breeding
• Cryopreservation
• Quarantine
• Rederivation
• Model In-Licensing
• Genetic Testing
• Others
 o Surgical Services
 o Line Rescue Services
 o In Vivo Pharmacology Services

By Technology
• Crispr
• Microinjection
• Embryonic Stem Cell Injection
• Nuclear Transfer
• Other Technologies

By Therapeutic Area
• Toxicology
• Oncology
 o New Product Launches for Oncology Research
 o Continuous Grants/Funds to Support Cancer Research Studies
• Immunology and Inflammation
• Neurology
• Diabetes
• Others

By End User
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions
• Contract Research Organizations (CRO)

By Care
• Cages
• Feed
• Bedding
• Other Care Products

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Rat Model Market By Model Type, By Service, By Technology, By Therapeutic Area, By End User, By Care and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Global Rat Model Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Rat Model Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Rat Model Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Global Rat Model Market, By Model Type Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Outbred Rats
  7.2. Inbred Rats
  7.3. Knockout/Genetically Engineered Rats
  7.4. Hybrid/Congenic Rats
  7.5. Conditioned/Surgically Modified Rats
  7.6. Immunodeficient Rats

8. Global Rat Model Market, By Service Historical Analysis and Forecast 2020-2027 (USD Million)
  8.1. Breeding
  8.2. Cryopreservation
  8.3. Quarantine
  8.4. Rederivation
  8.5. Model In-Licensing
  8.6. Genetic Testing
  8.7. Others
      8.8.1. Surgical Services
      8.8.2. Line Rescue Services
      8.8.3. In Vivo Pharmacology Services

9. Global Rat Model Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)
  9.1. Crispr
  9.2. Microinjection
  9.3. Embryonic Stem Cell Injection
  9.4. Nuclear Transfer
  9.5. Other Technologies

10. Global Rat Model Market, By Therapeutic Area  Historical Analysis and Forecast 2020-2027 (USD Million)
  10.1. Toxicology
  10.2. Oncology
  10.3. Immunology and Inflammation
  10.4. Neurology
  10.5. Diabetes
  10.6. Others

11. Global Rat Model Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
  11.1. Pharmaceutical & Biotechnology Companies
  11.2. Academic & Research Institutions
  11.3. Contract Research Organizations (CRO)

12. Global Rat Model Market, By Care Historical Analysis and Forecast 2020-2027 (USD Million)
  12.1. Cages
  12.2. Feed
  12.3. Bedding
  12.4. Other Care Products
\
13. North America Rat Model Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
  13.1. Introduction
  13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
       13.2.1. U.S.A
       13.2.2. Canada
       13.2.3. Mexico
  13.3. Market Size (USD Million) Forecast for North America 2020-2027

14. Latin America Rat Model Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         14.2.1. Brazil
         14.2.2. Venezuela
         14.2.3. Argentina
         14.2.4. Rest of Latin America
   14.3. Market Size (USD Million) Forecast for Latin America 2020-2027

15. Europe Rat Model Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         15.2.1. Germany
         15.2.2. U.K        
         15.2.3. France
         15.2.4. Italy
         15.2.5. Spain
         15.2.6. Russia
         15.2.7. Poland
         15.2.8. Rest of Europe
   15.3. Market Size (USD Million) Forecast for Europe 2020-2027

16. Asia Pacific Rat Model Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   16.1. Introduction
   16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         16.2.1. Japan
         16.2.2. China
         16.2.3. India
         16.2.4. Australia and New Zealand
         16.2.5. ASEAN
         16.2.6. Rest of Asia Pacific
   16.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027  

17. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   17.1. Introduction
   17.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         17.2.1. Saudi Arabia
         17.2.2. UAE
         17.2.3. South Africa
         17.2.4. Egypt
   17.3. Market Size (USD Million) Forecast for MEA 2020-2027

18. Market Share Analysis and Competitive Landscape  
   18.1. Global Landscape - Key Players, Revenue and Presence
   18.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   18.3. Global Emerging Companies
   18.4.  North America - Market Share Analysis and Key Regional Players
   18.5.  Europe - Market Share Analysis and Key Regional Players
   18.6.  Asia Pacific - Market Share Analysis and Key Regional Players
   18.7.  Global Key Player - Growth Matrix

19. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   19.1. Charles River Laboratories International, Inc.
         19.1.1. Company Overview
         19.1.2. Product Portfolio
         19.1.3. SWOT Analysis
         19.1.4. Financial Overview
         19.1.5. Strategic Overview
   19.2. Taconic Biosciences, Inc.
         19.2.1. Company Overview
         19.2.2. Product Portfolio
         19.2.3. SWOT Analysis
         19.2.4. Financial Overview
         19.2.5. Strategic Overview
   19.3. Envigo
         19.3.1. Company Overview
         19.3.2. Product Portfolio
         19.3.3. SWOT Analysis
         19.3.4. Financial Overview
         19.3.5. Strategic Overview
   19.4. Laboratory Corporation of America Holdings
         19.4.1. Company Overview
         19.4.2. Product Portfolio
         19.4.3. SWOT Analysis
         19.4.4. Financial Overview
         19.4.5. Strategic Overview
   19.5. Janvier Labs
         19.5.1. Company Overview
         19.5.2. Product Portfolio
         19.5.3. SWOT Analysis
         19.5.4. Financial Overview
         19.5.5. Strategic Overview          
   19.6. Genoway S.A.
         19.6.1. Company Overview
         19.6.2. Product Portfolio
         19.6.3. SWOT Analysis
         19.6.4. Financial Overview
         19.6.5. Strategic Overview      
   19.7. Biomere
         19.7.1. Company Overview
         19.7.2. Product Portfolio
         19.7.3. SWOT Analysis
         19.7.4. Financial Overview
         19.7.5. Strategic Overview
   19.8. Transposagen Biopharmaceuticals, Inc.
         19.8.1. Company Overview
         19.8.2. Product Portfolio
         19.8.3. SWOT Analysis
         19.8.4. Financial Overview
         19.8.5. Strategic Overview
   19.9. Horizon Discovery Group PLC
         19.9.1. Company Overview
         19.9.2. Product Portfolio
         19.9.3. SWOT Analysis
         19.9.4. Financial Overview
         19.9.5. Strategic Overview
   19.10. Transviragen, Inc.
         19.10.1. Company Overview
         19.10.2. Product Portfolio
         19.10.3. SWOT Analysis
         19.10.4. Financial Overview
         19.10.5. Strategic Overview
   19.11.SAGE Labs
         19.11.1. Company Overview
         19.11.2. Product Portfolio
         19.11.3. SWOT Analysis
         19.11.4. Financial Overview
         19.11.5. Strategic Overview
   19.12.Covance, Inc.
         19.12.1. Company Overview
         19.12.2. Product Portfolio
         19.12.3. SWOT Analysis
         19.12.4. Financial Overview
         19.12.5. Strategic Overview
   19.13.Biomedical Research Models
         19.13.1. Company Overview
         19.13.2. Product Portfolio
         19.13.3. SWOT Analysis
         19.13.4. Financial Overview
         19.13.5. Strategic Overview

20. Pre and Post COVID-19 Impact
   20.1. Positive influence on the healthcare industry
   20.2. The financial disruption of the manufacturing sector
   20.3. Impact of COVID-19 on emerging companies
   20.4. Significant mandates in the healthcare regulations initiated by administrations
   20.5. The overall economic slowdown of the developing and developed nations

21. FutureWise SME Key Takeaway Points for Client

Tables

Figures